Country Overviews: market research reports

... of demand continues to be met through foreigndonations, indicating the dire situation in the country. At the same time, the domestic industry continuesto struggle, without much hope for government finances or credit extensions, which will ...  |  read more...

... public drugexpenditure. The Health Insurance Institute of Slovenia's savings target for the first year as a result ofthis new policy is relatively limited, and as part of this figure comes from new controls on wholesalers'margins, ...  |  read more...

... after theUS, Japan and China. Furthermore, per capita spending is high, there is a sizeable pensionablepopulation and regulations are transparent. These are factors BMI believes will continue to bring insubstantial income for companies operating in ...  |  read more...

... exceeded CNY1,100bn ($175bn). While it is unclear why the total investment exceeded the budget, it is evident that the Chinese healthcare system in general is largely underfunded. Introduction Review the principle aims of the 2009-11 ...  |  read more...

... overview, market environment, and expenditure and medical provider forecasts. National health expenditure segments include hospital care, physicians' and clinical services, pharmaceuticals and other medical products, nursing home care, home health care, and other health expenditures. ...  |  read more...

... growth, the increasingly ageing population in Sweden means expandingeldercare demands and will continue to attract medical devices suppliers, healthcare providers andpharmaceuticals players. Headline Expenditure Projections Pharmaceuticals: SEK42.84bn (US$6.60bn) in 2011 to an expected SEK42.13bn (US$6.08bn)in ...  |  read more...

... squeezed as PHARMAC attempts to make real cuts from its prescribing budget. Headline Expenditure Forecasts Pharmaceuticals: NZD1.35bn (US$1.07bn) in 2011 to NZD1.36bn (US$1.01bn) in 2012; +1.1% in local currency and -5.6% in US dollar terms. ...  |  read more...

... The recent drug contamination scandal in Punjab has renewed calls for the formation of an independent, centralised drug authority. Unless the matter is addressed adequately, multinational drugmakers will continue to struggle with cumbersome bureaucracy, which ...  |  read more...

... the dichotomy of the market: the long-term macroeconomic and demographic indicators are highly favourable, but the government's continued involvement and intervention, particularly in regard to drug pricing, has meant innovative drugmakers have to sell their ...  |  read more...

... overly significant impact on our growth projections over our five- and 10-year forecast periods. We have maintained our growth rate for 2012 of 4.0% in local currency terms, but we warn this is equivalent to ...  |  read more...

A forensic analysis with statistics on national and regional health infrastructure and provision. An essential source of highly detailed business data.  |  read more...

... understand world medical marketplaces, and be able to answer quickly those questions that arise daily, is essential. That is why this current and comprehensive market statistics source is an invaluable aid for every executive. Proven ...  |  read more...

... healthcare market to grow at a fast pace. The Brazilian Government has adopted several initiatives and implemented proper plans and policies that resulted in positive development of the overall healthcare services and facilities. According to ...  |  read more...